Stratification of RA patients according to ACPA positivity revealed that SF-derived CD19+ cells of ACPA+ RA patients show significantly lower PU.1 expression compared to ACPA- patients (Fig. 5a). The gene discussed is CD19; the disease is rheumatoid arthritis.